USPUSP-NF
This is a preview of
USP-NF/PF content.
Subscriber?
Access here!
Not a subscriber?
Learn more!
Letermovir Tablets

BRIEFING

Letermovir Tablets. Because there is no existing USP monograph for this drug product, a new monograph based on validated methods of analysis is proposed.

  1. The liquid chromatographic procedure used in the Assay and Dissolution test was validated using the Kromasil 100-5-C18 brand of column with L1 packing. The typical retention time for letermovir is about 4 min.

  2. The liquid chromatographic procedure used in the Organic Impurities test was validated using the Kromasil 100-5-C18 brand of column with L1 packing. The typical retention time for letermovir is about 40 min.

 This monograph is contingent on FDA approval of a product that meets the proposed monograph specifications. Please see the Pending Monograph Guideline for additional information.

 (SM1: J. Kilari)

 Case ID—SUB-1243, SUB-2901

USP REFERENCE STANDARDS FOR PURCHASE

USP Letermovir RS
USP Letermovir Related Compound B RS
This is a preview of
USP-NF/PF content.
Subscriber?
Access here!
Not a subscriber?
Learn more!